Telling Japan’s Opportunity Story

As a direct result of DCI’s work, Amgen announced a joint venture with Astellas Pharma in May 2013 to provide new medicines in Japan.

Daiki Nakajima, Business Development Team

Amgen economic development lead generation

The Challenge

JETRO needed to identify and arrange face-to-face meetings with companies considering investment in Asia, particularly in the wake of the devastating tsunami.


The DCI Strategy

Utilize a “predictive model” to identify companies exhibiting changes that forecast a site location need.  Schedule in-person appointments and teleconference opportunities with prospective investors with an interest in investment.  Qualify each interested company to ensure they met the program guidelines for project size and timeline.


The Results

  • DCI arranged a total of 19 face-to-face meetings between corporate decision makers and JETRO’s team in New York City.
  • The outreach campaign also identified 44 suspects that represent future investment opportunities.
  • Of the companies contacted during the relationship, major life sciences company Amgen moved forward with an investment in Japan.